Nolvadex Warning

June 27, 2002
BioPharm International Editors

FDA and AstraZeneca have added a boxed warning and strengthened the Warnings section of the Nolvadex (tamoxifen citrate) tablets label to inform healthcare professionals about new risk information. MedWatch Safety Information http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#nolvad

FDA and AstraZeneca have added a boxed warning and strengthened the Warnings section of the Nolvadex (tamoxifen citrate) tablets label to inform healthcare professionals about new risk information. MedWatch Safety Information http://www.fda.gov/medwatch/SAFETY/2002/safety02.htm#nolvad